As at June 30, 2018, the Corporation had 138,024,481 Common Shares, 20,789,144 common share purchase warrants and 3,881,345 options outstanding.
Other than as described below, there have been no material changes in the consolidated share and loan capital of the Corporation since June 30, 2018, the date of the Corporation's mostrecent unaudited condensed interim consolidated financial statements:
On July 5, 2018, the Corporation issued 399,900 Common Shares and 399,900 commonshare purchase warrants on the exercise of an aggregate of 399,900 previously issued compensation options, another 399,900 Common Shares were issued upon the exercise of these 399,900 commonshare purchase warrants;
On July 11, 2018, the Corporation issued 303,290 CommonShares to the former shareholders of Nanoleaf pursuant to an adjustment clause under the Nanoleaf Acquisition;
On August 9, 2018, the Corporation issued 5,865 Common Shares to the former shareholders of Nanoleaf pursuant to an adjustment clause under the Nanoleaf Acquisition;
On August 10, 2018, the Corporation issued 23,736,100 August 2018 Special Warrants pursuant to the August 2018 Offering. As consideration for their services in connection with the August 2018 Offering, the agents received 930,680 compensation options, each of which is exersiable into one Common Share and one common share purchase warrant at an exercise price of $1.60 . See" Summary Description of the Business–Recent Developments";
On August 30, 2018, the Corporation issued 7,825 Common Shares on the exercise of 7,825 previously issued common share purchase warrants;
On September 5, 2018, the Corporation issued 31,250 Common Shares on the conversion of $50,000 principal amount of convertible debentures;
On September 6, 2018, the Corporation issued 450,000 Common Shares upon the conversion of $720,000 principal amount of convertible debentures;
On September 7, 2018, the Corporation issued 39,375 Common Shareson the exercise of 39,375 previously issued common share purchase warrants;
On September 13, 2018, the Corporation issued 28,875 Common Shares on the exercise of 28,875 common share purchase warrants;
On September 13, 2018, the Corporation issued 106,250 Common Shares on the conversion of $170,000 principal amount of convertible debentures;
On September 20, 2018, the Corporation issued 10,500 Common Shares on the exercise of 10,500 common share purchase warrants;
On October 3, 2018, the Corporation granted an aggregate of 6,059,250 options pursuant to the Stock Option Plan of the Corporation;
On October 5, 2018, the Corporation issued an aggregate of 1,240,231 Common Shares in settlement of a previously granted share-based award to a key management employee; and
On October 5, 2018, the Corporation issued an aggregate of 23,376,100 Common Shares an 23,376,100 common share purchase warrants pursuant to the deemed exercise of the August 2018 Special Warrants
https://www.sedar.com/...=03&projectNo=02830024&docId=4404881
--------------------------------------------------
plus,
hat it has closed its previously announced bought deal financing of units (the “Units”) at a price of $1.65 per Unit (the “Offering Price”) for aggregate gross proceeds of $50,077,50
plus,
Wayland Group Announces Closing of Over-Allotment Option for Additional Gross Proceeds of $7.5 Million
plus
it has issued an additional 4,552,500 Units (the “Units”) at a price of $1.65 per Unit (the“Offering Price”) for total gross proceeds of $7,511,625
plus,
Dated as ofOctober31, 2018
https://www.sedar.com/...=03&projectNo=02836328&docId=4409426
|